In a world first, the Medicines and Healthcare Products Regulatory Agency (MHRA) has approved trofolastat to detect cancerous lesions in men with prostate cancer.
A meta-analysis finds that women who breastfeed are less likely to develop heart conditions or diseases, or die from cardiovascular disease than women who do not breastfeed.
NHS cancer patients will be the first to experience drone chemotherapy, which furthers the NHS net zero strategy, as it cuts down travel time and distance.
Ketil Widerberg, General Manager of Oslo Cancer Cluster, describes the complexities of implementing precision cancer medicine in Norway and suggests a way forward.
Cervical cancer is a disease affecting thousands of women in the UK with around 3,200 new cases diagnosed every year, can developments in cervical screening and digital cytology help?
Sabine Mai and Aline Rangel-Pozzo, at the CancerCare Manitoba Research Institute and The University of Manitoba, Winnipeg, Canada, discuss genomic instability in relation to 3D spatial organization of telomeres.
Tokyo court hearings are underway for almost $5 million in damages, for six individuals who developed thyroid cancer as a result of the Fukushima disaster.
Between 1992 and 2013, survival rates for young adults with colorectal cancer (CRC) only improved for Caucasian patients – no increase was seen for those from Black, Hispanic or Asian communities
Banning commercially available indoor tanning beds would prevent skin cancer and reduce deaths from the most serious form of skin cancer known as melanoma.
